MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment"

  • 2024 International Congress

    Physical Activity Levels and Demographic Characteristics in Individuals with Huntington’s Disease: Insights from the ENROLL-HD Database in an Argentinian Movement Disorder Center

    M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, G. Peker, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: To assess PA levels in individuals enrolled in the ENROLL-HD database, and compare demographic characteristics between PE practitioners, and non-practitioners Background: Neurological disorders have been…
  • 2024 International Congress

    Sustained Chorea Improvements with Long-Term, Once-Daily Valbenazine in Adults with Huntington’s Disease

    E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, R. Mehanna, S. Hinton, O. Klepitskaya, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To present interim analyses from KINECT®-HD2 (NCT04400331), an ongoing open-label study of once-daily valbenazine (VBZ) for chorea associated with Huntington’s disease (HD). Background: In…
  • 2024 International Congress

    Treatment Effect Sizes of Once-Daily Valbenazine for Tardive Dyskinesia and for Chorea Associated with Huntington’s Disease: A Post-Hoc Analysis of Phase 3 Clinical Trial Data

    R. Mehanna, R. Hauser, E. Furr Stimming, L. Citrome, E. Kayson, J. Goldstein, O. Klepitskaya, S. Hinton, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To assess the treatment effect size of once-daily valbenazine for tardive dyskinesia (TD) and for chorea associated with Huntington’s disease (HD) using data from…
  • 2024 International Congress

    ​​Deciphering the Huntington’s Disease Research Landscape: A Comprehensive Bibliometric and Trend Analysis

    S. Khankar, T. Lalotra, A. Subhedar, S. Joshi, S. Mast, A. Bhonsale (Nagpur, India)

    Objective: To map the Huntington's Disease research landscape, identifying key trends, gaps, and the most impactful studies to guide future research directions and therapeutic strategies.…
  • 2024 International Congress

    Mapping the Efficacy Landscape: A Network Meta-Analysis of Pharmacological Interventions in Huntington’s Disease

    A. Bhonsale, V. Suresh, B. Javed, M. Shamim, T. Dave, V. Ghosh, S. Sen, M. Muneer, D. Dey, M. Jayan, B. Dhakal, S. Vasipalli, R. Jena (Nagpur, India)

    Objective: To evaluate and compare the efficacy of pharmacological interventions for Huntington's Disease through a network meta-analysis, identifying the most effective treatments. Background: Huntington’s Disease…
  • 2024 International Congress

    Huntington’s Disease Pathogenesis, Molecular Factors, and Potential for Combinatorial Therapies: A Focus on BDNF and NMDA Receptor Therapies

    M. Mistry, J. Pace, E. Guivatchian, J. Hinman (Fort Worth, USA)

    Objective: This paper outlines current therapeutic options for HD, and ultimately suggests taking a combinatorial therapeutic approach to slow HD progression by simultaneously treating multiple…
  • 2024 International Congress

    Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration

    RN. Surbakti, RK. Praja (Palangka Raya, Indonesia)

    Objective: This study aimed to investigate the shifting trends (2019-2024) in research on Huntington's disease (HD)based on bibliometric lens. Background: Huntington's disease is a movement…
  • 2024 International Congress

    Exploring the Impact of Mechanoacoustic Vibration Therapy on Mobility, Bone Density, and Postural Stability in Perimenopause Women with Huntington’s disease

    S. Devi, R. Chauhan (Narsan, India)

    Objective: This study aimed to investigate the effects of mechanoacoustic vibration therapy on mobility, bone mineral density (BMD), and postural instability in perimenopause  women with…
  • 2024 International Congress

    Patient and Caregiver Experiences with Huntington Disease: Emotions, Challenges, and Unmet Needs in the Patient Journey

    A. Peyser Levin, E. Kinjo, R. Ribalov, N. Chaijale, A. Yaari (Tel Aviv, Israel)

    Objective: To describe patients' emotional journey from symptom onset and diagnosis to current state and to identify challenges and unmet needs in Huntington disease (HD).…
  • 2024 International Congress

    Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

    C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)

    Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley